Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Dapeng Li, David R. Martinez, Alexandra Schäfer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 188
Aluminum Adjuvants—‘Back to the Future’
Donatello Laera, Harm HogenEsch, Derek T. O’Hagan
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1884-1884
Open Access | Times Cited: 39
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 30
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 24
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Longping V. Tse, Yixuan J. Hou, Elizabeth McFadden, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 715
Open Access | Times Cited: 23
Broad-spectrum pan-genus and pan-family virus vaccines
Chee Wah Tan, Sophie Valkenburg, Leo L. M. Poon, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 902-916
Open Access | Times Cited: 22
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
C. Pierre, Lily E. Adams, Jaclyn S. Higgins, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1011569-e1011569
Open Access | Times Cited: 11
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Rajeshwer S. Sankhala, Kerri G. Lal, Jaime L. Jensen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults
Yíngyún Caì, Seme Diallo, Kim Rosenthal, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Closed Access | Times Cited: 7
Nanoparticles in clinical trials of COVID-19: An update
Abdur Rauf, Tareq Abu‐Izneid, Anees Ahmed Khalil, et al.
International Journal of Surgery (2022) Vol. 104, pp. 106818-106818
Open Access | Times Cited: 32
Sortases: structure, mechanism, and implications for protein engineering
Jeanine F. Amacher, John M. Antos
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 7, pp. 596-610
Closed Access | Times Cited: 6
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals
Alexander A. Cohen, Jennifer R. Keeffe, Ariën Schiepers, et al.
Cell (2024) Vol. 187, Iss. 20, pp. 5554-5571.e19
Open Access | Times Cited: 6
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals
Alexander A. Cohen, Jennifer R. Keeffe, Ariën Schiepers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Deciphering Fc-effector functions against SARS-CoV-2
Guillaume Beaudoin-Bussières, Andrés Finzi
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 756-768
Closed Access | Times Cited: 5
Construction and immune effect evaluation of the S protein heptad repeat-based nanoparticle vaccine against porcine epidemic diarrhea virus
Dan Yang, Xinglin Wang, Xu Yang, et al.
Virology (2024) Vol. 596, pp. 110113-110113
Closed Access | Times Cited: 5
Design of SARS-CoV-2 RBD Immunogens to Focus Immune Responses Towards Conserved Coronavirus Epitopes
Caitlin Harris, A. Brenda Kapingidza, James Emmanuel San, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS‐CoV‐2
Jun Liu, Yan Wu, George F. Gao
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access
Viral and immune profiles during the first wave of SARS-CoV-2 infection in hospitalized patients in Sardinia, Italy
Giulietta Venturi, Alessandra Gallinaro, Claudia Fortuna, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Plattformtechnologien in der Impfstoffentwicklung
Eberhard Hildt
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2025)
Open Access
Ferritin-based nanomedicine for disease treatment
Yuanjun Zhu, Yuefeng Zhu, Tianmiao Cao, et al.
Medical Review (2023) Vol. 3, Iss. 1, pp. 49-74
Open Access | Times Cited: 12
mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
Brian Montoya, Carolina R. Melo‐Silva, Lingjuan Tang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1790-1804
Open Access | Times Cited: 4
Next-Generation Vaccine Development with Nanomaterials: Recent Advances, Possibilities, and Challenges
Shamitha Shetty, Pablo Cordero Alvarado, Deleah Pettie, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 273-306
Closed Access | Times Cited: 4
Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines
Jie Zhou, Zezhong Liu, Guangxu Zhang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top